Global Hepatitis B Vaccines Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5686168   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Hepatitis B vaccines are preventive immunizations designed to provide protection against the Hepatitis B virus, which can cause a potentially serious liver infection. The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother to her newborn during childbirth. The Hepatitis B vaccine is typically administered in a series of three or four shots, with the second dose given one month after the first, the third dose given six months after the first, and a booster shot recommended in certain situations. Vaccination is recommended for individuals at risk of Hepatitis B exposure, including healthcare workers, people with multiple sexual partners, newborns of infected mothers, and individuals with certain medical conditions. Hepatitis B vaccination has been highly successful in preventing new infections and reducing the long-term risks associated with Hepatitis B, such as chronic liver disease and liver cancer.
According to DIResearch's in-depth investigation and research, the global Hepatitis B Vaccines market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Hepatitis B Vaccines include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, Serum Institute, LG Life Sciences etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Hepatitis B Vaccines. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hepatitis B Vaccines market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Hepatitis B Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hepatitis B Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Hepatitis B Vaccines Include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
Serum Institute
LG Life Sciences
Hepatitis B Vaccines Product Segment Include:
Yeast Derived
CHO Derived
Hepatitis B Vaccines Product Application Include:
Children
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Hepatitis B Vaccines Industry PESTEL Analysis
Chapter 3: Global Hepatitis B Vaccines Industry Porter's Five Forces Analysis
Chapter 4: Global Hepatitis B Vaccines Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Hepatitis B Vaccines Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Hepatitis B Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Hepatitis B Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Hepatitis B Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Hepatitis B Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Hepatitis B Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Hepatitis B Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Hepatitis B Vaccines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Hepatitis B Vaccines Market Overview

1.1 Product Definition and Statistical Scope

1.2 Hepatitis B Vaccines Product by Type

1.2.1 Global Hepatitis B Vaccines Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Yeast Derived

1.2.3 CHO Derived

1.3 Hepatitis B Vaccines Product by Application

1.3.1 Global Hepatitis B Vaccines Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Children

1.3.3 Adult

1.4 Global Hepatitis B Vaccines Market Revenue and Sales Analysis

1.4.1 Global Hepatitis B Vaccines Market Size Analysis (2019-2030)

1.4.2 Global Hepatitis B Vaccines Market Sales Analysis (2019-2030)

1.4.3 Global Hepatitis B Vaccines Market Sales Price Trend Analysis (2019-2030)

1.5 Hepatitis B Vaccines Market Development Status and Trends

1.5.1 Hepatitis B Vaccines Industry Development Status Analysis

1.5.2 Hepatitis B Vaccines Industry Development Trends Analysis

2 Hepatitis B Vaccines Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Hepatitis B Vaccines Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Hepatitis B Vaccines Market Analysis by Regions

4.1 Hepatitis B Vaccines Overall Market: 2023 VS 2024 VS 2030

4.2 Global Hepatitis B Vaccines Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Hepatitis B Vaccines Revenue and Market Share by Region (2019-2024)

4.2.2 Global Hepatitis B Vaccines Revenue Forecast by Region (2025-2030)

4.3 Global Hepatitis B Vaccines Sales and Forecast Analysis (2019-2030)

4.3.1 Global Hepatitis B Vaccines Sales and Market Share by Region (2019-2024)

4.3.2 Global Hepatitis B Vaccines Sales Forecast by Region (2025-2030)

4.4 Global Hepatitis B Vaccines Sales Price Trend Analysis (2019-2030)

5 Global Hepatitis B Vaccines Market Size by Type and Application

5.1 Global Hepatitis B Vaccines Market Size by Type

5.1.1 Global Hepatitis B Vaccines Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Hepatitis B Vaccines Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Hepatitis B Vaccines Market Size by Application

5.2.1 Global Hepatitis B Vaccines Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Hepatitis B Vaccines Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Hepatitis B Vaccines Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Hepatitis B Vaccines Market Size by Type

6.3.1 North America Hepatitis B Vaccines Sales by Type (2019-2030)

6.3.2 North America Hepatitis B Vaccines Revenue by Type (2019-2030)

6.4 North America Hepatitis B Vaccines Market Size by Application

6.4.1 North America Hepatitis B Vaccines Sales by Application (2019-2030)

6.4.2 North America Hepatitis B Vaccines Revenue by Application (2019-2030)

6.5 North America Hepatitis B Vaccines Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Hepatitis B Vaccines Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Hepatitis B Vaccines Market Size by Type

7.3.1 Europe Hepatitis B Vaccines Sales by Type (2019-2030)

7.3.2 Europe Hepatitis B Vaccines Revenue by Type (2019-2030)

7.4 Europe Hepatitis B Vaccines Market Size by Application

7.4.1 Europe Hepatitis B Vaccines Sales by Application (2019-2030)

7.4.2 ? Europe Hepatitis B Vaccines Revenue by Application (2019-2030)

7.5 Europe Hepatitis B Vaccines Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Hepatitis B Vaccines Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Hepatitis B Vaccines Market Size by Type

8.3.1 China Hepatitis B Vaccines Sales by Type (2019-2030)

8.3.2 China Hepatitis B Vaccines Revenue by Type (2019-2030)

8.4 China Hepatitis B Vaccines Market Size by Application

8.4.1 China Hepatitis B Vaccines Sales by Application (2019-2030)

8.4.2 China Hepatitis B Vaccines Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Hepatitis B Vaccines Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Hepatitis B Vaccines Market Size by Type

9.3.1 APAC (excl. China) Hepatitis B Vaccines Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Hepatitis B Vaccines Revenue by Type (2019-2030)

9.4 APAC (excl. China) Hepatitis B Vaccines Market Size by Application

9.4.1 APAC (excl. China) Hepatitis B Vaccines Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Hepatitis B Vaccines Revenue by Application (2019-2030)

9.5 APAC (excl. China) Hepatitis B Vaccines Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Hepatitis B Vaccines Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Hepatitis B Vaccines Market Size by Type

10.3.1 Latin America Hepatitis B Vaccines Sales by Type (2019-2030)

10.3.2 Latin America Hepatitis B Vaccines Revenue by Type (2019-2030)

10.4 Latin America Hepatitis B Vaccines Market Size by Application

10.4.1 Latin America Hepatitis B Vaccines Sales by Application (2019-2030)

10.4.2 Latin America Hepatitis B Vaccines Revenue by Application (2019-2030)

10.5 Latin America Hepatitis B Vaccines Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Hepatitis B Vaccines Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Hepatitis B Vaccines Market Size by Type

11.3.1 Middle East & Africa Hepatitis B Vaccines Sales by Type (2019-2030)

11.3.2 Middle East & Africa Hepatitis B Vaccines Revenue by Type (2019-2030)

11.4 Middle East & Africa Hepatitis B Vaccines Market Size by Application

11.4.1 Middle East & Africa Hepatitis B Vaccines Sales by Application (2019-2030)

11.4.2 Middle East & Africa Hepatitis B Vaccines Revenue by Application (2019-2030)

11.5 Middle East & Africa Hepatitis B Vaccines Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Hepatitis B Vaccines Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Hepatitis B Vaccines Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Hepatitis B Vaccines Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Hepatitis B Vaccines Average Sales Price by Manufacturers (2020-2024)

12.2 Hepatitis B Vaccines Competitive Landscape Analysis and Market Dynamic

12.2.1 Hepatitis B Vaccines Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 GSK

13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 GSK Hepatitis B Vaccines Product Portfolio

13.1.3 GSK Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 NCPC

13.2.1 NCPC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 NCPC Hepatitis B Vaccines Product Portfolio

13.2.3 NCPC Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Merck

13.3.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Merck Hepatitis B Vaccines Product Portfolio

13.3.3 Merck Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Bio Kangtai

13.4.1 Bio Kangtai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Bio Kangtai Hepatitis B Vaccines Product Portfolio

13.4.3 Bio Kangtai Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Dynavax

13.5.1 Dynavax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Dynavax Hepatitis B Vaccines Product Portfolio

13.5.3 Dynavax Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Hissen

13.6.1 Hissen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Hissen Hepatitis B Vaccines Product Portfolio

13.6.3 Hissen Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 KM Biologics

13.7.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 KM Biologics Hepatitis B Vaccines Product Portfolio

13.7.3 KM Biologics Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Serum Institute

13.8.1 Serum Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Serum Institute Hepatitis B Vaccines Product Portfolio

13.8.3 Serum Institute Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 LG Life Sciences

13.9.1 LG Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 LG Life Sciences Hepatitis B Vaccines Product Portfolio

13.9.3 LG Life Sciences Hepatitis B Vaccines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Hepatitis B Vaccines Industry Chain Analysis

14.2 Hepatitis B Vaccines Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Hepatitis B Vaccines Typical Downstream Customers

14.4 Hepatitis B Vaccines Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support